FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like Idera, Biocryst Tie the Knot and Transform Into a Rare Disease Pharma January 21, 2018 A Look at Gilead's Possible New Drug Strategy May 30, 2017 Opening Of Digital Innovation Lab Underscores Syngenta AG Commitment To Innovation May 16, 2017
